Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
vitamin d3 (1 trial)
Efesovir (1 trial)
Tuberculosis (Phase 3)
Tuberculosis, Multidrug-Resistant (Phase 3)
Trials (2 total)
Trial APIs (2 total)